FDA Inspection
California Pharmacy & Compounding CenterCalifornia Pharmacy & Compounding Center – FDA Inspection, Oct 17, 2014
Record Details
This FDA Inspection record concerns California Pharmacy & Compounding Center, with an inspection on October 17, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 17, 2014
- Product Type
- Drugs
View Company Profile
ID · dbfc05bf-fc7f-46db-8374-72488e4c3d50
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 900112
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.125(a)Strict control not exercised over labeling issued
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of California Pharmacy & Compounding Center
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 21, 2017 | Not classified | Los Angeles District Office | Drug Quality Assurance |
| August 31, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 25, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for California Pharmacy & Compounding Center
- FDA Inspection 1074872 - 2018-12-17
- FDA Inspection 1013560 - 2017-04-21
- FDA Inspection 986751 - 2016-08-31
- FDA Inspection 893386 - 2014-08-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.